+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Generic Drugs Market by Type (Simple Generic, Specialty Generic), Route of Administration (Inhalable, Injectable, Oral), Indication, Distribution - Forecast 2024-2030- Product Image
Global Generic Drugs Market by Type (Simple Generic, Specialty Generic), Route of Administration (Inhalable, Injectable, Oral), Indication, Distribution - Forecast 2024-2030- Product Image
Sale

Global Generic Drugs Market by Type (Simple Generic, Specialty Generic), Route of Administration (Inhalable, Injectable, Oral), Indication, Distribution - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5888623
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Generic Drugs Market size was estimated at USD 299.16 billion in 2023, USD 316.27 billion in 2024, and is expected to grow at a CAGR of 5.91% to reach USD 447.45 billion by 2030.

The generic drugs are designed to be identical in dosage form, strength, route of administration, quality, performance characteristics, and intended use to their branded counterparts and are sold at a lower price once the patent protection of the original brand-name drug has expired. These products offer a vital cost-saving advantage to consumers and healthcare systems worldwide.

Generic drugs find their application across a broad spectrum of therapeutic areas, including cardiovascular, diabetes, neurology, oncology, and infectious diseases, among others. The end-users of generic drugs are primarily healthcare providers such as hospitals, clinics, and pharmacies, and they are sold directly to consumers through over-the-counter (OTC) sales.

The affordability of generic drugs compared to their branded counterparts remains a primary driver for market growth. Growing government support for the use of generic drugs through favorable regulations and policies to reduce healthcare costs is driving the growth of the generic drug market. The rising incidences of chronic conditions globally are expanding the need for generic drugs. : Concerns over the quality and efficacy of generic drugs and stringent and varying regulatory policies across different countries hamper the market growth. The growing development of novel drug delivery systems to enhance efficacy and patient compliance is expected to create opportunities for market growth. Expanding into biosimilar products, with research focused on reducing production costs and proving similarity to originator biologics, is anticipated to fuel market growth.

Regional Insights

The Americas stands as the highly developing market for generic drugs, driven by a high demand for affordable healthcare solutions and strong support from governmental policies. Recently, initiatives such as the Generic Drug User Fee Amendments (GDUFA) aim to speed up the approval process for generic drugs, bolstering the market. Consumer trust in generics is high, with a large percentage of prescriptions filled with generic drugs annually. Asia-Pacific's generic drug market is experiencing rapid growth, fueled by governmental reforms aimed at encouraging the development and approval of high-quality generics. The region is focusing on innovation with investments in R&D and streamlining regulatory processes to bolster the local industry.

In the EU, the regulatory framework encourages the development and circulation of generic drugs, balancing the need for innovation and competition. Various EU-wide initiatives support market access for generics, fostering a competitive environment that benefits consumers. The market for generic drugs in the Middle East & Africa is growing, with governments implementing policies to promote the use of generics. This is part of a broader strategy to enhance healthcare affordability and accessibility in the region.

Market Trends by Segment

  • Type: Expanding applications of for treating complex and chronic conditions
  • Distribution: Emerging preference for online pharmacies for convenience, accessibility, and competitive pricing

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

BDR Pharma launches generic drug for fungal infections at 1/3rd the cost

BDR Pharmaceutical introduced Zisavel capsules, a generic azole antifungal treatment aimed at addressing invasive aspergillosis and mucormycosis fungal infections at a significantly reduced cost. Zisavel is positioned as a cost-effective alternative, costing only a third of the price of current treatments. BDR Pharmaceuticals' initiative seeks to enhance the accessibility of essential medication, particularly isavuconazole, making it as affordable as other new-generation antifungal agents such as voriconazole and posaconazole.

Amneal Launches Authorized Generic for Xyrem (sodium oxybate) and Receives FDA Approval for Five Complex Generics

Amneal Pharmaceuticals, Inc. announced the U.S. introduction of its authorized generic version of Xyrem (Sodium Oxybate) oral solution, a central nervous system depressant aiding patients aged seven and above in managing cataplexy and excessive daytime sleepiness associated with narcolepsy. Alongside this significant release, Amneal shared news of receiving U.S. FDA approvals for five complex generics, including three injections, highlighting dexmedetomidine injection, acknowledged for addressing a current FDA shortage.

Mediplus Health Services launches own brand of generic medicines

Mediplus Health Services expanded into the generic drug segment by introducing its proprietary line of generic medications, now accessible throughout its extensive 4,200-store network. This ambitious venture is supported by collaborations with renowned Contract Drug Manufacturing Organisations (CDMOs), including Akums India and Windlas Biotech, targeting the production of 706 different generic drugs.

Key Company Profiles

The report delves into recent significant developments in the Generic Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alkem Laboratories Ltd., Amneal Pharmaceuticals Inc, Aspen Holdings, Aurobindo Pharma Limited, Baxter International Inc., Cipla Ltd, Dr. Reddy’s Laboratories Ltd., Eli Lilly and Company, Endo International plc., Fresenius SE & Co. KGaA., Gilead Sciences, Inc., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC., Johnson & Johnson Services, Inc., Lupin Limited, Mylan N.V. by Viatris Inc., Pfizer Inc., Sandoz International GmbH by Novartis Group, Sanofi S.A., STADA Arzneimittel AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., and Zydus Lifesciences Ltd.

This research report offers invaluable insights into various crucial aspects of the Generic Drugs Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic diseases and the need for cost-effective medications
5.1.1.2. Favorable government support for generic drugs
5.1.1.3. Growing availability of generic drugs through online pharmacies
5.1.2. Restraints
5.1.2.1. Preference for branded drugs by patients and physicians
5.1.3. Opportunities
5.1.3.1. Ongoing R&D activities associated with the development of generic drugs
5.1.3.2. Increasing patent expirations and strategic long-term partnerships to manufacture generic drugs
5.1.4. Challenges
5.1.4.1. Concerns associated with quality and manufacturing variability
5.2. Market Segmentation Analysis
5.2.1. Type: Expanding applications of for treating complex and chronic conditions
5.2.2. Distribution: Emerging preference for online pharmacies for convenience, accessibility, and competitive pricing
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Generic Drugs Market, by Type
6.1. Introduction
6.2. Simple Generic
6.3. Specialty Generic
7. Generic Drugs Market, by Route of Administration
7.1. Introduction
7.2. Inhalable
7.3. Injectable
7.4. Oral
8. Generic Drugs Market, by Indication
8.1. Introduction
8.2. Cancer
8.3. Cardiovascular Diseases
8.4. Central Nervous System Disorders
8.5. Diabetes
8.6. Gastrointestinal Diseases
8.7. Hormones & Related Diseases
8.8. Infectious Diseases
8.9. Respiratory Diseases
9. Generic Drugs Market, by Distribution
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas Generic Drugs Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Generic Drugs Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Generic Drugs Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. BDR Pharma launches generic drug for fungal infections at 1/3rd the cost
13.3.2. Amneal Launches Authorized Generic for Xyrem (sodium oxybate) and Receives FDA Approval for Five Complex Generics
13.3.3. Mediplus Health Services launches own brand of generic medicines
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. GENERIC DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GENERIC DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GENERIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GENERIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL GENERIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GENERIC DRUGS MARKET DYNAMICS
FIGURE 7. GLOBAL GENERIC DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL GENERIC DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENERIC DRUGS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL GENERIC DRUGS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GENERIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES GENERIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. GENERIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. GENERIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GENERIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GENERIC DRUGS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL GENERIC DRUGS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL GENERIC DRUGS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL GENERIC DRUGS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL GENERIC DRUGS MARKET SIZE, BY SIMPLE GENERIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL GENERIC DRUGS MARKET SIZE, BY SIMPLE GENERIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL GENERIC DRUGS MARKET SIZE, BY SPECIALTY GENERIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL GENERIC DRUGS MARKET SIZE, BY SPECIALTY GENERIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL GENERIC DRUGS MARKET SIZE, BY INHALABLE, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL GENERIC DRUGS MARKET SIZE, BY INHALABLE, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL GENERIC DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL GENERIC DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL GENERIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL GENERIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL GENERIC DRUGS MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL GENERIC DRUGS MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL GENERIC DRUGS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL GENERIC DRUGS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL GENERIC DRUGS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL GENERIC DRUGS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL GENERIC DRUGS MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL GENERIC DRUGS MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL GENERIC DRUGS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL GENERIC DRUGS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL GENERIC DRUGS MARKET SIZE, BY HORMONES & RELATED DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL GENERIC DRUGS MARKET SIZE, BY HORMONES & RELATED DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL GENERIC DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL GENERIC DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL GENERIC DRUGS MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL GENERIC DRUGS MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 73. CANADA GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 74. CANADA GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 75. CANADA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 76. CANADA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 77. CANADA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 78. CANADA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 79. CANADA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 80. CANADA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 81. MEXICO GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 82. MEXICO GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 83. MEXICO GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 84. MEXICO GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 85. MEXICO GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 86. MEXICO GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 87. MEXICO GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 88. MEXICO GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES GENERIC DRUGS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES GENERIC DRUGS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 108. ASIA-PACIFIC GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. AUSTRALIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 112. AUSTRALIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 113. AUSTRALIA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 114. AUSTRALIA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 115. AUSTRALIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 116. AUSTRALIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 117. CHINA GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 118. CHINA GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 119. CHINA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 120. CHINA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 121. CHINA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 122. CHINA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 123. CHINA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 124. CHINA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 125. INDIA GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 126. INDIA GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 127. INDIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 128. INDIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 129. INDIA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 130. INDIA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 131. INDIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 132. INDIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. INDONESIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 136. INDONESIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 137. INDONESIA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 138. INDONESIA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 139. INDONESIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 140. INDONESIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 141. JAPAN GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 142. JAPAN GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 143. JAPAN GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 144. JAPAN GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 145. JAPAN GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 146. JAPAN GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 147. JAPAN GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 148. JAPAN GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 151. MALAYSIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 152. MALAYSIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 153. MALAYSIA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 154. MALAYSIA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 155. MALAYSIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 156. MALAYSIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. PHILIPPINES GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 160. PHILIPPINES GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 161. PHILIPPINES GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 162. PHILIPPINES GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 163. PHILIPPINES GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 164. PHILIPPINES GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 167. SINGAPORE GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 168. SINGAPORE GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 169. SINGAPORE GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 170. SINGAPORE GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 171. SINGAPORE GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 172. SINGAPORE GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 175. SOUTH KOREA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 176. SOUTH KOREA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 177. SOUTH KOREA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 178. SOUTH KOREA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 179. SOUTH KOREA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 180. SOUTH KOREA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 183. TAIWAN GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 184. TAIWAN GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 185. TAIWAN GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 186. TAIWAN GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 187. TAIWAN GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 188. TAIWAN GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 189. THAILAND GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. THAILAND GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. THAILAND GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 192. THAILAND GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 193. THAILAND GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 194. THAILAND GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 195. THAILAND GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 196. THAILAND GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 199. VIETNAM GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 200. VIETNAM GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 201. VIETNAM GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 202. VIETNAM GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 203. VIETNAM GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 204. VIETNAM GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 215. DENMARK GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 216. DENMARK GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 217. DENMARK GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 218. DENMARK GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 219. DENMARK GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 220. DENMARK GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 221. DENMARK GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 222. DENMARK GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 223. EGYPT GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 224. EGYPT GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 225. EGYPT GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 226. EGYPT GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 227. EGYPT GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 228. EGYPT GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 229. EGYPT GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 230. EGYPT GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 231. FINLAND GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. FINLAND GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. FINLAND GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 234. FINLAND GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 235. FINLAND GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 236. FINLAND GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 237. FINLAND GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 238. FINLAND GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 239. FRANCE GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 240. FRANCE GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 241. FRANCE GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 242. FRANCE GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 243. FRANCE GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 244. FRANCE GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 245. FRANCE GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 246. FRANCE GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 247. GERMANY GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 248. GERMANY GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 249. GERMANY GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 250. GERMANY GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 251. GERMANY GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 252. GERMANY GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 253. GERMANY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 254. GERMANY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. ISRAEL GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 258. ISRAEL GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 259. ISRAEL GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 260. ISRAEL GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 261. ISRAEL GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 262. ISRAEL GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 263. ITALY GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 264. ITALY GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 265. ITALY GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 266. ITALY GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 267. ITALY GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 268. ITALY GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 269. ITALY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 270. ITALY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 273. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 274. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 275. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 276. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 277. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 278. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. NIGERIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 282. NIGERIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 283. NIGERIA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 284. NIGERIA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 285. NIGERIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 286. NIGERIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 287. NORWAY GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 288. NORWAY GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 289. NORWAY GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 290. NORWAY GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 291. NORWAY GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 292. NORWAY GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 293. NORWAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 294. NORWAY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 295. POLAND GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 296. POLAND GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 297. POLAND GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 298. POLAND GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 299. POLAND GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 300. POLAND GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 301. POLAND GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 302. POLAND GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 303. QATAR GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 304. QATAR GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 305. QATAR GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 306. QATAR GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 307. QATAR GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 308. QATAR GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 309. QATAR GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 310. QATAR GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 311. RUSSIA GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 312. RUSSIA GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 313. RUSSIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 314. RUSSIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 315. RUSSIA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 316. RUSSIA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 317. RUSSIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 318. RUSSIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 320. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 322. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 324. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 326. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 328. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 330. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 332. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 333. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 334. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 335. SPAIN GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 336. SPAIN GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 337. SPAIN GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 338. SPAIN GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 339. SPAIN GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 340. SPAIN GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 341. SPAIN GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 342. SPAIN GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 343. SWEDEN GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 344. SWEDEN GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 345. SWEDEN GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 346. SWEDEN GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 347. SWEDEN GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 348. SWEDEN GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 349. SWEDEN GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 350. SWEDEN GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 351. SWITZERLAND GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 352. SWITZERLAND GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 353. SWITZERLAND GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 354. SWITZERLAND GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 355. SWITZERLAND GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 356. SWITZERLAND GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 357. SWITZERLAND GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 358. SWITZERLAND GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 359. TURKEY GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 360. TURKEY GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 361. TURKEY GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 362. TURKEY GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 363. TURKEY GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 364. TURKEY GENERIC DRUGS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 365. TURKEY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 366. TURKEY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 367. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 368. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 369. UNITED ARAB EMIRATES GENERIC DR

Companies Mentioned

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Amneal Pharmaceuticals Inc
  • Aspen Holdings
  • Aurobindo Pharma Limited
  • Baxter International Inc.
  • Cipla Ltd
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • Endo International plc.
  • Fresenius SE & Co. KGaA.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • Hikma Pharmaceuticals PLC.
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Mylan N.V. by Viatris Inc.
  • Pfizer Inc.
  • Sandoz International GmbH by Novartis Group
  • Sanofi S.A.
  • STADA Arzneimittel AG
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Zydus Lifesciences Ltd

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 316.27 Billion
Forecasted Market Value ( USD ) by 2030 $ 447.45 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Global Markets for Generic Drugs - Product Image

Global Markets for Generic Drugs

  • Report
  • 126 Pages
  • Global
From
US Generic Drug Market Report by Segment, Therapy Area, Drug Delivery, Distribution Channel 2024-2032 - Product Image

US Generic Drug Market Report by Segment, Therapy Area, Drug Delivery, Distribution Channel 2024-2032

  • Report
  • 139 Pages
  • United States
From
North America Generic Drugs Market, Competition, Forecast & Opportunities, 2018-2028 - Product Image

North America Generic Drugs Market, Competition, Forecast & Opportunities, 2018-2028

  • Report
  • 136 Pages
  • North America
From
Generic Drugs - Global Strategic Business Report - Product Image

Generic Drugs - Global Strategic Business Report

  • Report
  • 711 Pages
  • Global
From
Global Branded Generics Market by Product (Trade Named Generics, Value-Added), Drug Type (Alkylating Agents, Anti-depressants, Anti-epileptics), Route of Administration, Indication, Distribution Channel - Forecast 2024-2030 - Product Image

Global Branded Generics Market by Product (Trade Named Generics, Value-Added), Drug Type (Alkylating Agents, Anti-depressants, Anti-epileptics), Route of Administration, Indication, Distribution Channel - Forecast 2024-2030

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.